Skip to main content
. 2021 Sep 24;13(19):4772. doi: 10.3390/cancers13194772

Table 1.

Demographics and baseline characteristics.

Variables Normal Weight
(n = 48 Patients)
Overweight
(n = 33 Patients)
Obese
(n = 14 Patients)
p-Value
Patients 48 (50.5%) 33 (34.7%) 14 (14.7%) -
Height (cm) 171 ± 8 168 ± 8 168 ± 10 0.097
Weight (kg) 66 ± 8 76 ± 8 99 ± 12 <0.01
Gender 0.89
Male 26 (54.2%) 19 (57.6%) 7 (50%)
Female 22 (45.8%) 14 (42.4%) 7 (50%)
Age (years) 62.1 ± 1.7 64.9 ± 1.5 61.3 ± 2.5 0.39
ASA, score (%) <0.01
1–2 39 (82%) 23 (70%) 5 (36%)
3–4 9 (18%) 10 (30%) 9 (64%)
Diabetes mellitus 0.21
Yes 13 (27.1%) 8 (24.2%) 6 (42.9%)
No 34 (70.8) 22 (66.7%) 6 (42.9%)
Missing 1 (2.1%) 3 (9.1%) 2 (14.2%)
Cirrhosis/Fibrosis 0.91
Yes 5 (10.4%) 4 (12.1%) 2 (14.3%)
No 43 (89.6%) 29 (87.9%) 12 (85.7%)
Clinical Jaundice 0.79
Yes 38 (79.1%) 27 (81.8%) 10 (71.4%)
No 10 (20.9%) 6 (18.2%) 4 (28.6%)
CA 19-9, (U/L) 292.7 ± 101.6 340.2 ± 582.5 338.6 ± 669 0.89
CEA, (ng/mL) 6.2 ± 2.3 2.8 ± 0.8 2.1 ± 0.6 0.31
Peak Bilirubin preoperative (ummol/L) 44.1 ± 6.8 70.8 ± 15.4 33.9 ± 13.1 0.11
Preoperative drainage 0.29
No 7 (14.6%) 6 (18.2%) 4 (28.6%)
PTCD 7 (14.6%) 2 (6.1%) 0 (0%)
ERCP 33 (68.8%) 20 (60.6%) 8 (57.1%)
Both 0 (0%) 2 (6.1%) 1 (7.1%)
Missing 1 (2.1%) 3 (9.1%) 1 (7.1%)
Portal vein involvement on imaging 0.693
Yes 12 (25%) 8 (24.2) 2 (14.3)
No 36 (75%) 25 (75.8) 12 (85.7)
Bismuth-Corlette classification 0.64
I 2 (4.2%) 2 (6.1%) 2 (14.3%)
II 4 (8.3%) 2 (6.1%) 2 (14.3%)
IIIa 6 (12.5%) 4 (12.1%) 1 (7.1%)
IIIb 7 (14.6%) 3 (9.1%) 2 (14.3%)
IV 25 (52.1%) 20 (60.6%) 4 (28.6%)
Missing 4 (8.3%) 2 (6.1%) 3 (21.4)